Role of Inflammation in Atrial Fibrillation Pathophysiology and Management
Top Cited Papers
Open Access
- 1 January 2015
- journal article
- review article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 79 (3), 495-502
- https://doi.org/10.1253/circj.cj-15-0138
Abstract
Atrial fibrillation (AF) is the most common clinically relevant arrhythmia, but the methods available for treating AF and its complications (of which the most important is thrombogenesis), as well as for assessing AF risk and underlying pathophysiology, are largely limited. Emerging evidence suggests a significant role of inflammation in the pathogenesis of AF. That evidence includes elevated serum levels of inflammatory biomarkers in AF subjects, the expression of inflammatory markers in cardiac tissues of AF patients and animal models of AF, and beneficial effects of anti-inflammatory drugs in experimental AF paradigms. Inflammation is suggested to be linked to various pathological processes, such as oxidative stress, apoptosis, and fibrosis, that promote AF substrate formation. Inflammation has also been associated with endothelial dysfunction, platelet activation, and coagulation cascade activation, leading to thrombogenesis. Thus, inflammation may contribute to both the occurrence/maintenance of AF and its thromboembolic complications. Here, we review the evidence for a role of inflammation and inflammatory biomarkers in the risk management and treatment of AF. We also summarize the current knowledge of inflammation-dependent cellular and molecular mechanisms in AF pathophysiology and their potential as therapeutic targets. (Circ J 2015; 79: 495–502)Keywords
This publication has 79 references indexed in Scilit:
- An Immunohistochemical Analysis of Tissue Thrombin Expression in the Human AtriaPLOS ONE, 2013
- How can we cure a heart “in flame”? A translational view on inflammation in heart failureBasic Research in Cardiology, 2013
- Fish Oil and Post-Operative Atrial FibrillationJournal of the American College of Cardiology, 2013
- High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trialEuropean Heart Journal, 2011
- Post-operative atrial fibrillation: a maze of mechanismsEP Europace, 2011
- Myeloperoxidase acts as a profibrotic mediator of atrial fibrillationNature Medicine, 2010
- Role of inflammation and oxidative stress in atrial fibrillationHeart Rhythm, 2009
- Intracardiac and extracardiac markers of inflammation during atrial fibrillationHeart Rhythm, 2009
- NF-κB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin IIAmerican Journal of Physiology-Cell Physiology, 2008
- Interleukin-6 and atrial fibrillation in patients with coronary artery disease: Data from the Heart and Soul StudyAmerican Heart Journal, 2007